AK

Abhishek Kumar Deshwal

Active Director Director DIN 08490069
DIN 08490069 First appointment Jun 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 1 historical roles
Total affiliations 6 Since Jun 2019
Shareholding value •••• Premium profile

About Abhishek Kumar Deshwal

Data last updated:

Abhishek Kumar Deshwal is a Director at 4Amd Pharmaceuticals Private Limited (since 2023), Additional Director at Dwarika-Pharmaceuticals Private Limited (since 2025) and Director at Sri Ji Foods & Technology Private Limited (since 2026), and holds 2 more current directorships. The companies operate in Healthcare and Infrastructure and Utilities. The 2 current companies with reported revenue have a combined latest revenue of ₹2.58 Cr; the largest is 4Amd Pharmaceuticals Private Limited at ₹2.39 Cr (FY 2025). Earlier, Abhishek Kumar Deshwal was a Director at Abhiyansh Transporters Private Limited (from 2019).

DIN 08490069
Primary Designation Director
Industry Healthcare
First Appointment 21 Jun 2019
Oldest Company Age 7 yrs
Largest company 4Amd Pharmaceuticals Private Limited · ₹2.39 Cr (FY 2025)
Combined revenue ₹2.58 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
4Amd Pharmaceuticals Private Limited U46497UP2023PTC185959
Director20 Jul 20232023₹2.39 Cr (FY 2025)Active
Additional Director03 Nov 20252022₹19.8 Lakh (FY 2025)Active
Director03 Jan 20262026Active
Mahanandan Charity Foundation U85499UP2025NPL218410
Director05 Mar 20252025Active
Andycox India Private Limited U74999UP2020PTC133342
Additional Director11 Sep 20232020Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Jun 20192019Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Abhiyansh Transporters Private Limited
Sri Ji Foods & Technology Private Limited
Dwarika-Pharmaceuticals Private Limited
Mahanandan Charity Foundation
Premium access

Shareholding and investment profile for Abhishek Kumar Deshwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhishek Kumar Deshwal

Abhishek Kumar Deshwal currently holds 5 directorships: 4Amd Pharmaceuticals Private Limited (Director, since 20 Jul 2023, revenue ₹2.39 Cr (FY 2025)); Dwarika-Pharmaceuticals Private Limited (Additional Director, since 03 Nov 2025, revenue ₹19.8 Lakh (FY 2025)); Sri Ji Foods & Technology Private Limited (Director, since 03 Jan 2026); Mahanandan Charity Foundation (Director, since 05 Mar 2025); Andycox India Private Limited (Additional Director, since 11 Sep 2023).

Abhishek Kumar Deshwal was first appointed on 21 Jun 2019 as Director at Abhiyansh Transporters Private Limited. The most recent appointment on record is 03 Jan 2026 at Sri Ji Foods & Technology Private Limited.

The 2 current companies of Abhishek Kumar Deshwal that report revenue have a combined latest revenue of ₹2.58 Cr: 4Amd Pharmaceuticals Private Limited ₹2.39 Cr (FY 2025); Dwarika-Pharmaceuticals Private Limited ₹19.8 Lakh (FY 2025).

Abhishek Kumar Deshwal held 1 earlier board appointment: Abhiyansh Transporters Private Limited (Director, from 21 Jun 2019).

The current boards of Abhishek Kumar Deshwal's companies include Aditi Mishra (4Amd Pharmaceuticals Private Limited), Prateek Karanwal (Dwarika-Pharmaceuticals Private Limited), Ramesh Chandra Mishra (Mahanandan Charity Foundation), Devendra Singh (Andycox India Private Limited), Monika Tomer (Andycox India Private Limited), Priyanka Srivastava (Andycox India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available